Kimberly Scearce-Levie

8PUBLICATIONS
105CO-AUTHORS
Clinical pharmacology and therapeuticsBiomaterialsMolecular targetsGene and molecular therapyMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 22, 2023
LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease.

Danna Jennings, Sarah Huntwork-Rodriguez, Maurits F J M Vissers

|Jan 12, 2023
A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer's disease models.

Bettina van Lengerich, Lihong Zhan, Dan Xia

|Jun 08, 2022
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease.

Danna Jennings, Sarah Huntwork-Rodriguez, Anastasia G Henry

|Feb 28, 2022
Molecular architecture determines brain delivery of a transferrin receptor-targeted lysosomal enzyme.

Annie Arguello, Cathal S Mahon, Meredith E K Calvert

|May 13, 2021
Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's disease.

Gai Ayalon, Seung-Hye Lee, Oskar Adolfsson

|Jul 03, 2020
Leveraging preclinical models for the development of Alzheimer disease therapeutics.

Kimberly Scearce-Levie, Pascal E Sanchez, Joseph W Lewcock

Pageof 2

Frequent Collaborators

3 joint publications

Anastasia G Henry

3 joint publications

Pascal E Sanchez

3 joint publications

Matthew D Troyer

3 joint publications

Hoang Nguyen